Jefferies raises Immuneering price target to $3.50 from $1.50 on cancer data
Jefferies raises Immuneering price target to $3.50 from $1.50 on cancer dataSource: Investing.com
أخبار الاستثمار والأسواق المالية من موقع Investing.com
Jefferies raises Immuneering price target to $3.50 from $1.50 on cancer dataSource: Investing.com
Triple Flag stock downgraded by BMO despite price target increaseSource: Investing.com
Autoliv stock initiated at outperform by RBC on market dominanceSource: Investing.com
Raymond James downgrades GMS stock rating on acquisition uncertaintySource: Investing.com
RBC sees deep value in Just Group despite YTD underperformanceSource: Investing.com

Exclusive-BYD slows production, delays capacity expansion at China factories, sources saySource: Reuters
JPMorgan lifts Arkema to Neutral, sees valuation support amid weak backdropSource: Investing.com
Lacrosse league scores ESPN investment and media rights dealSource: Investing.com

European shares edge up as Middle East truce lifts sentimentSource: Reuters
European stocks edge higher as Middle East ceasefire holds; Powell in spotlightSource: Investing.com